Clinical Trial Update: Lidocaine for Oxaliplatin-induced Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating lidocaine for oxaliplatin-induced neuropathy has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Colorectal Cancer
• Neuropathy Painful

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Neuropathy, Painful, Chemotherapy-induced Peripheral Neuropathy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-03-09